España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Orgenesis
ORGS
OTCQX
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$2.90
0.78
36.95%
At close: -
Get Report
Comment
Orgenesis (ORGS) Forecast
News
Earnings
Orgenesis (ORGS) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Orgenesis (OTC:ORGS) Stock
Orgenesis Stock (OTC: ORGS)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, November 13, 2024
Orgenesis Q3 EPS $(1.93) Down From $(0.12) Yo...
Benzinga Newsdesk
Friday, October 18, 2024
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
Dow Falls Over 100 Points; Netflix Posts Upbeat Results
Avi Kapoor
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Why Intuitive Surgical Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Wednesday, September 25, 2024
Trading Halt: Halt status updated at 8:55:00 ...
Benzinga Newsdesk
Tuesday, September 24, 2024
Trading Halt: Halted at 7:50:00 p.m. ET - Tra...
Benzinga Newsdesk
Why Maison Solutions Shares Are Trading Higher By Around 91%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Monday, September 23, 2024
Why Orgenesis (ORGS) Stock Is Down 23% Today
Henry Khederian
Orgenesis shares are trading lower after the ...
Benzinga Newsdesk
Orgenesis Approves A 1-for-10 Reverse Stock S...
Benzinga Newsdesk
Thursday, August 29, 2024
Orgenesis Announces Results From A Real-World...
Benzinga Newsdesk
Wednesday, August 14, 2024
Orgenesis shares are trading higher after the...
Benzinga Newsdesk
Orgenesis Announces Strategic Partnership Wit...
Benzinga Newsdesk
Tuesday, August 13, 2024
Why Rumble Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Friday, August 09, 2024
CORRECTION: Orgenesis Q2 EPS Loss Of $(0.23) ...
Benzinga Newsdesk
Friday, July 12, 2024
Orgenesis Entered Purchase Deal With Theracel...
Benzinga Newsdesk
Orgenesis Enters Asset Purchase Agreement Wit...
Benzinga Newsdesk
Friday, June 21, 2024
Why Kaival Brands Innovations Shares Are Trading Lower By 47%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
Tuesday, May 21, 2024
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Orgenesis Q1 EPS $(0.29) Down From $0.17 YoY,...
Benzinga Newsdesk
Monday, April 22, 2024
Orgenesis Inc Files For Mixed Shelf Of Up To ...
Benzinga Newsdesk
Monday, April 15, 2024
Orgenesis Says Major Transformation Underway ...
Benzinga Newsdesk
Wednesday, April 10, 2024
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
Germfree And Orgenesis Announce Asset Purchas...
Benzinga Newsdesk
Thursday, April 04, 2024
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Wednesday, April 03, 2024
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Tuesday, April 02, 2024
Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Monday, April 01, 2024
Why Nuvve Holding Shares Are Trading Lower By Around 30%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
Wednesday, March 13, 2024
Orgenesis Consortium Awarded €1.5M Grant From...
Benzinga Newsdesk
Monday, March 04, 2024
Orgenesis Announces $2.3M Private Placement
Benzinga Newsdesk
Thursday, February 29, 2024
Orgenesis Consortium Awarded €2.0M EUR Grant ...
Benzinga Newsdesk
Monday, February 19, 2024
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Thursday, February 15, 2024
Why Herbalife Shares Are Trading Lower By Around 36%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
Dakota Gold And 2 Other Stocks Under $3 Insiders Are Buying
Avi Kapoor
Wednesday, January 31, 2024
EXCLUSIVE: Orgenesis Acquires Control of Octomera, Takes One Step Closer To Progressing Its Decentralized Immuno-Oncology Portfolio To Clinic
Vandana Singh
EXLCUSIVE: Orgenesis Tells Benzinga 'Metalmar...
Benzinga Newsdesk
EXCLUSIVE: Orgenesis Tells Benzinga It Has En...
Benzinga Newsdesk
Friday, January 19, 2024
Why TransCode Therapeutics Shares Are Trading Lower By Over 24%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
Monday, November 13, 2023
Orgenesis Q3 2023 EPS $0.43 Up From $0.05 YoY...
Benzinga Newsdesk
Wednesday, November 08, 2023
Orgenesis Inc. Announces Pricing Of $1.1M Reg...
Benzinga Newsdesk
Tuesday, October 31, 2023
Why JetBlue Airways Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
Why Pinterest Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket
Lisa Levin
Orgenesis Announces Withdrawal Of Its Previou...
Benzinga Newsdesk
Monday, October 30, 2023
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
Orgenesis Announces Proposed Underwritten Pub...
Benzinga Newsdesk
Show More
